1Lee YK & Salminen S (1995) The coming of age of probiotics. Trends Food Sci Technol 6, 241–245.
2Salminen S, Ouwehand A, Benno Y & Lee YK (1999) Probiotics: how should they be defined? Trends Food Sci Technol 10, 107–110.
3De Rodas BZ, Gilliland SE & Maxwell CV (1996) Hypocholesterolemic action of Lactobacillus acidophilus ATCC 43121 and calcium in swine with hypercholesterolemia induced by diet. J Dairy Sci 79, 2121–2128.
4Lidbeck A, Geltner-Allinger U, Orrhage KM, Ottova L, Brismar B, Gustafsson JA, Rafter JJ & Nord CE (1991) Impact of Lactobacillus acidophilus supplements on the faecal microflora and soluble faecal bile acids in colon cancer patients. Microbiol Ecol Health Dis 4, 81–88.
5Kalliomaki M, Salminen S, Poussa T, Arvilommi H & Isolauri E (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361, 1869–1871.
6Kimoto H, Kurisaki J, Tsuji NM, Ohmomo S & Okamoto T (1999) Lactococci as probiotic strains: adhesion to human enterocyte-like Caco-2 cells and tolerance to low pH and bile. Lett Appl Microbiol 29, 313–316.
7Kimoto H, Ohmomo S, Nomura M, Kobayashi M & Okamoto T (2000) In vitro studies on probiotic properties of lactococci. Milchwissenschaft 55, 245–249.
8Kimoto H, Ohmomo S & Okamoto T (2002) Cholesterol removal from media by lactococci. J Dairy Sci 85, 3182–3188.
9Kimoto H, Mizumachi K, Okamoto T & Kurisaki J (2004) New Lactococcus strain with immunomodulatory activity: enhancement of Th1-type immune response. Microbiol Immunol 48, 75–82.
10Nomura M, Kimoto H, Someya Y, Furukawa S & Suzuki I (1998) Production of gamma-aminobutyric acid by cheese starters during cheese ripening. J Dairy Sci 81, 1486–1491.
11Nomura M, Kimoto H, Someya Y & Suzuki I (1999) Novel characteristic for distinguishing Lactococcus lactis subsp. lactis from subsp. cremoris. Int J Syst Bacteriol 49, Pt 1, 163–166.
12Inoue K, Shirai T, Ochiai H, Kasao M, Hayakawa K, Kumura M & Sansawa H (2003) Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 57, 490–495.
13Hayakawa K, Kimura M, Kasaha K, Matsumoto K, Sansawa H & Yamori Y (2004) Effect of a gamma-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Nutr 92, 411–417.
14Mahncke HW, Bronstone A & Merzenich MM (2006) Brain plasticity and functional losses in the aged: scientific bases for a novel intervention. Prog Brain Res 157, 81–109.
15Solana R & Mariani E (2000) NK and NK/T cells in human senescence. Vaccine 18, 1613–1620.
16Voss P & Siems W (2006) Clinical oxidation parameters of aging. Free Radic Res 40, 1339–1349.
17Stock H, Schneider A & Strauss E (2004) Osteoporosis: a disease in men. Clin Orthop Relat Res : 425, 143–151.
18Lei H, Wang B, Li WP, Yang Y, Zhou AW & Chen MZ (2003) Anti-aging effect of astragalosides and its mechanism of action. Acta Pharmacol Sin 24, 230–234.
19Kim SY, Kim SJ, Lee YJ, Kim WG, Park WS, Sim YC & Lee SJ (2004) Protective effects of dietary soy isoflavones against UV-induced skin-aging in hairless mouse model. J Am Coll Nutr 23, 157–162.
20Rubino C, Farace F, Dessy LA, Sanna MP & Mazzarello V (2005) A prospective study of anti-aging topical therapies using a quantitative method of assessment. Plast Reconstr Surg 115, 1156–1162.
21Kim JH, Lee BC, Kim JH, Sim GS, Lee DH, Lee KE, Yun YP & Pyo HB (2005) The isolation and antioxidative effects of vitexin from Acer palmatum. Arch Pharm Res 28, 195–202.
22Hori T, Kiyoshima J, Shida K & Yasui H (2002) Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin Diagn Lab Immunol 9, 105–108.
23Matsumoto S, Watanabe N, Imaoka A & Okabe Y (2001) Preventive effects of Bifidobacterium-and Lactobacillus-fermented milk on the development of inflammatory bowel disease in senescence-accelerated mouse P1/Yit strain mice. Digestion 64, 92–99.
24Sambrook P & Cooper C (2006) Osteoporosis. Lancet 367, 2010–2018.
25Takeda T, Hosokawa M, Takeshita S, et al. (1981) A new murine model of accelerated senescence. Mech Ageing Dev 17, 183–194.
26Ohata H, Nishikawa H, Hirai K, Kato K & Miyamoto M (1996) Relationship of impaired brain glucose metabolism to learning deficit in the senescence-accelated mouse. Neurosci Lett 217, 37–40.
27Li L, Ng TB, Gao W, Li W, Fu M, Niu SM, Zhao L, Chen RR & Liu F (2005) Antioxidant activity of gallic acid from rose flowers in senescence accelerated mice. Life Sci 77, 230–240.
28Hosokawa M, Kasai R, Higuchi K, et al. (1984) Grading score system: a method for evaluation of the degree of senescence in senescence accelerated mouse (SAM). Mech Ageing Dev 26, 91–102.
29Rogosa M, Mitchell JA & Wiseman RF (1951) A selective medium for the isolation and enumeration of oral and fecal lactobacilli. J Bacteriol 62, 132–133.
30Wozniak A, Wozniak B, Drewa G & Drewa T (2003) Lipid peroxidation and antioxidant capacity in selected tissues of healthy black C57BL/6J mice and B16 melanoma-bearing mice. Melanoma Res 13, 19–22.
31Naito M & Yamanaka K (1978) Arteriosclerosis and hydroperoxide. Nihon Rohnen Igakuzasshi 15, 187–191.
32Faloni AP, Sasso-Cerri E, Katchburian E & Cerri PS (2007) Decrease in the number and apoptosis of alveolar bone osteoclasts in estrogen-treated rats. J Priodontal Res 42, 193–201.
33Huth PJ, DiRienzo DB & Miller GD (2006) Major scientific advances with dairy foods in nutrition and health. J Dairy Sci 89, 1207–1221.
34Wildner M, Peters A, Raghuvanshi VS, Hohnloser J & Siebert U (2003) Superiority of age and weight as variables in predicting osteoporosis in postmenopausal white women. Osteoporos Int 14, 950–956.
35Lappin MB & Campbell JD (2000) The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy. Blood Rev 14, 228–239.
36Mascarucci P, Taub D, Saccani S, Paloma MA, Dawson H, Roth GS, Ingram DK & Lane MA (2001) Age-related changes in cytokine production by leukocytes in rhesus monkeys. Aging (Milan) 13, 85–94.
37Trinchieri G (1994) Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008–4027.
38Skurkovich S & Skurkovich B (2005) Anticytokine therapy, especially anti-interferon-gamma, as a pathogenetic treatment in TH-1 autoimmune diseases. Ann N Y Acad Sci 1051, 684–700.
39Inanir A, Ozoran K, Tutkak H & Mercerci B (2004) The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumor necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis. J Int Med Res 32, 570–582.
40Blair HC, Robinson LJ & Zaidi M (2005) Osteoclast signalling pathways. Biochem Biophys Res Commun 328, 728–738.
41Mitsuoka T (1992) Intestinal flora and aging. Nutr Rev 50, 438–446.
42Coconnier MH, Bernet MF, Kerneis S, Chauviere G, Fourniat J & Servin AL (1993) Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol Lett 110, 299–305.
43Beckman KB & Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78, 547–581.
44Salminen S, von Wright A, Morelli L, et al. (1998) Demonstration of safety of probiotics – a review. Int J Food Microbiol 44, 93–106.